MedCity News January 13, 2022
Chris Hasslinger

Providers, payers, and life sciences companies have a lot of room for growth using AI, and investors participating in JPM will continue to focus on companies that recognize this and act on it.

A battle over establishing trust and influence with patients and consumers is raging in healthcare. This was a topic that underscored many of the thousands of Zoom meetings among investors and industry insiders that took place this week surrounding J.P. Morgan’s 40th Annual Healthcare Conference. Like last year, the meetings were virtual, but the investment that will drive healthcare forward is very tangible.

The ongoing trend of consumerism and the use of technology in healthcare is the context for this competition. Patients have more choices in healthcare,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Technology, Trends
Digital Innovation Plus AI Tech Can Future-Proof the Enterprise
The AI frenzy could fall flat as companies hoard chips without enough data centers to host them
New AI drug discovery powerhouse Xaira rises with $1B in funding
EU regulation: AI Act will mean a raft of new requirements for ‘high-risk’ systems
Why nurses are protesting AI

Share This Article